You are here: Industry Insights > Dr Reddy’s

News List

Dr Reddy’s launch Lansoprazole DR orally disintegrating tablets in US expresspharma
February 23, 2021
They are indicated for the treatment of duodenal ulcers, gastric ulcers, GERD, erosive esophagitis and Zollinger-Ellison syndrome.
Dr Reddy’s initiates process for EUA of Sputnik V expresspharma
February 22, 2021
As part of the review process, Dr Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by February 2, 2021.
Dr Reddy’s launch Fluphenazine Hydrochloride Tablets in US expresspharma
February 20, 2021
Dr Reddy’s Laboratories announced the launch of Fluphenazine Hydrochloride Tablets, USP,a therapeutic equivalent generic version of Prolixin Tablets, 1mg, 2.5mg, 5mg, and 10mg, approved by the US Food and Drug Administration (USFDA).
Dr Reddy’s launch Capecitabine Tablets, USP in US expresspharma
February 18, 2021
Capecitabine tablet is indicated for the treatment of Adjuvant Colon Cancer, Metastatic Colorectal Cancer and Metastatic Breast Cancer.
Finished formulations from Dr Reddy’s worth Rs 80 lakhs gets stolen near Ambala during transit expresspharma
January 28, 2021
Dr Reddy’s Laboratories’ finished formulations stocks worth Rs 80 lakhs have been stolen near Ambala. The incident occurred while the consignment was being transported from its Global Distribution Center, Tepla, to the company’s CFA in Kochi.
Dr Reddy’s gets DCGI nod for Phase 3 clinical trial for Sputnik V vaccine expresspharma
January 18, 2021
The phase 3 study of Sputnik V will be conducted on 1500 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India.
Dr Reddy’s announces Sputnik V meets primary endpoint of safety in Phase 2 trial in India expresspharma
January 13, 2021
Dr Reddy’s submitted the phase 2 safety data for DCGI’s approval to continue phase 3 clinical trials.
Dr Reddy’s Laboratories launches Febuxostat Tablets in US expresspharma
January 12, 2021
They are used to treat gout, which is associated with an excess of a chemical called uric acid (urate) in the body.
Dr Reddy’s announces secondary listing of ADRs on NSE IFSC, GIFT City, Gujarat expresspharma
December 10, 2020
This is a secondary listing of ADRs that are currently issued by J.P. Morgan Chase Bank NA under its ADR Deposit agreement with Dr Reddy’s, and no further capital raising or issuance of new securities is involved.
Dr Reddy’s and RDIF begin clinical trials for Sputnik V vaccine in India expresspharma
December 02, 2020
The clinical trials are being conducted by JSS Medical Research as the clinical research partner.

Previous page 1 2 3 4 5 Next page